The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
NCT ID: NCT02666456
Last Updated: 2016-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
NCT04888455
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294
Chronic Neuropathy Following Chemotherapy
NCT02654691
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820
Objective Assessment of Sensory Nerve Fiber Sensitivity
NCT03596489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cross-sectional cohort
Patients with chronic peripheral neuropathic pain
QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires
Longitudinal cohort
Painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, Operation)
QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kiel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andras Binder
PD Dr. med.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DOLORisk WP4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.